OBJECTIVE
The aim of this study was to determine the validity of the hepatic apparent diffusion coefficient (ADC) measurement. The influence of differences in measured location and administration of Buscopan (hyoscine butylbromide) for ADC were assessed.
METHODS
SENSE-DWI (b = 0, 500) was obtained